Carl Zeiss Meditec AG (AFX)

Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA and an Investment Account
Sell

€32.44

Buy

€32.48

arrow-up€0.20 (+0.62%)

Prices updated at 20 Aug 2026, 15:06 CEST
| Prices minimum 15 mins delay
|
Prices in EUR
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world. Its ophthalmology segment, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, ...
FTSE EuroFirst 300
arrow-down-0.26%
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
our Investment Fees and Charges.

Most recent dividend payment

0.550
Cash Dividend
27 Mar 2026
05 Feb 2026
30 Mar 2026
31 Mar 2026

Total dividend yield

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20260.5500-
20250.6000-0.45
20241.1000-
20231.10000.22
20220.90000.80
20210.5000-0.23
20200.65000.18
20190.5500-
20180.55000.31
20170.42000.11

Total dividend yield data table

Year
chevron-l-regular
chevron-r-regular
Dividend yield (%)Buyback yield (%)
20261.80-
20251.50-
20242.423.77
20231.11-
20220.76-
20210.27-
20200.60-
20190.48-
20180.81-
20170.81-

Dividend per share

% of earnings paid to shareholders

Dividend per share data table

YearDividend per share
20260.5500
20250.6000
20241.1000
20231.1000
20220.9000
20210.5000
20200.6500
20190.5500
20180.5500
20170.4200

% of earnings paid to shareholders data table

YearPayout ratio (%)
202643.80
202537.27
202454.73
202333.85
202227.36
202118.94
202047.45
201930.73
201839.01
201726.75
Latest Financial Report as of 19 Aug 2026
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.